CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- 8-K Event Results of operations
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 2,179,372 shares (grant or award)
- 8-K Event Executive or director change
- 4 Grant or award CLO, CSO, and Corp Secretary acquired 2,179,372 shares (grant or award)
- 4 Grant or award PRINCIPAL ACCOUNTING OFFICER acquired 1,500,925 shares (grant or award)
- 4 Grant or award PRESIDENT & CEO acquired 3,000,000 shares (grant or award)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Unregistered share sale · Executive or director change · Shareholder vote results · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 3 of 19 · 363 filings